Eyedaptic

Augmented Reality Glasses for Vision Loss

Eyedaptic

Augmented Reality Glasses for Vision Loss

Laguna Hills, CA
Health Tech
Eyedaptic glasses use augmented reality technology to improve vision for those who suffer from AMD (age-related macular degeneration) and other central vision impairments.

$450,918

raised
357
Investors
$12M
Valuation
$0.80
Price per Share
$249.60
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
Reg CF
Offering

$450,918

raised
357
Investors
$12M
Valuation
$0.80
Price per Share
$249.60
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
Reg CF
Offering

Rewards

Get rewarded for investing more into Eyedaptic:

$250+
Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$500+
Investment
Tier 1
Quarterly Investor Newsletter from the CEO.
$1,000+
Investment
Tier 2
5% Bonus Shares
$2,500+
Investment
Tier 3
5% Product Price Discount
$5,000+
Investment
Tier 4
5% Product Price Discount + 5% Bonus Shares
$10,000+
Investment
Tier 5
10% Product Price Discount + 7% Bonus Shares
$25,000+
Investment
Tier 6
15% Product Price Discount + 10% Bonus Shares
$50,000+
Investment
Tier 7
Early new product access for Beta product + 15% Bonus Shares

Reasons to Invest

~400 million people worldwide suffer from various retinal diseases and nearly half of them suffer from AMD (Age-Related Macular Degeneration)
The only Augmented Reality glasses on the market, with over 40 degrees FOV (Field-of-View), to simulate natural vision!
Eyedaptic has received multiple finalist awards across a variety of ophthalmology and technology organizations such as Vision Tank Start-Up Competition and High Tech

*All images are of past prototypes or our production product. Final results may differ.

Overview


Enhancing vision to revitalize life

Eyedaptic CEO, Jay Cormier, founded the company after his grandmother started losing her vision due to the incurable condition, AMD (age-related macular degeneration). Upon further research, he discovered that AMD is the leading cause of vision loss for people over 60, and affects more than 15 million Americans and 170 million people worldwide (source).

Having had experience with Augmented Reality in the past, Cormier began to consider whether the technology could provide a solution to AMD. Cormier and his partner/CTO, Dave Watola, did not have medical backgrounds and so they sought the help of two ophthalmologists/retina specialists, Dr. Mitul Mehta and Dr. Brian Kim.


It quickly became clear to all of them that there was a significant need for a solution to AMD. So Cormier and Watola teamed up with the two doctors to found Eyedaptic.


*All images are of past prototypes or our production product. Final results may differ.

The Problem


No cure for the leading cause of age-related blindness

AMD is the leading cause of blindness for people over the age of 60. 90% of AMD cases are classified as Dry AMD, which has no cure (source). The disorder affects patients’ central vision, the fine, detailed segment of our vision that is used for reading or using a computer. This makes everyday tasks for sufferers extremely challenging, especially when many of us dependent on our phones, computers and other devices. 

The other 10% are referred to as Wet AMD, which is treated by several drugs that only slow the progression.

The Solution


AR technology proven to enhance vision!

Eyedaptic has harnessed the power of augmented reality technology to create a pair of glasses that simulate natural vision. Eyedaptic’s EYE2 glasses are the only Augmented Reality (AR) glasses on the market that capture over 40 degrees of the patients’ FOV (field of view).

*All images are of past prototypes or our production product. Final results may differ.

Our glasses have an adaptive user interface for hands-free autonomous usage, as well as a range of controls to customize the user experience. This allows users to function more normally with a more natural viewing experience.

The Market


Comparable to the global hearing aid market, valued at $8 billion

Of the over 400 million people worldwide with various retinal diseases, nearly half of them (approximately 170 million) suffer from some sort of AMD (source, source, source) Others suffer from retinal diseases like Stargardt’s Disease and DME (Diabetic Macular Edema) that also lead to a loss of central vision. Of the total macular degeneration patient population, it is estimated that roughly 90% suffer from dry AMD, which has no cure or therapy (source).

A comparable industry is that of global hearing aids, which has a similar market size, demographics and direct consumer payable. The hearing aid market is worth over $8B today and is projected to reach $14.45B by 2026 (source).

Our Traction


Multiple finalist awards since our recent launch, and a new product in the works

After a clinical study and a beta product release, Eyedaptic launched at the end of 2019 with its current iteration of hardware and software. In March, we announced our partnership with Vispero, the world-wide leader in low-vision aids and other assistive technologies. This provided us increased access to the low vision market. 

In the last year, Eyedaptic has received multiple awards across a variety of ophthalmology and technology organizations. A few noteworthy accolades include:

  • 2020 Vision Tank Start-Up Competition winner

  • 2020 Orange County High Tech Award Finalist

  • 2020 SXSW Pitch Finalist, 

  • 2nd place at Quick Pitch San Diego, 

  • Nominee for Orange County Business Journal’s Top Innovators of the Year


In addition, we have a new pair of glasses that features enhanced image quality, form factor, and comfort. This product includes a new hardware platform, increased software capability and a redesigned user interface. We have kicked off beta testing with a launch planned for early 2021.

The Business Model


Distributed through MDs and ODs, with high profit margins

Eyedaptic glasses are distributed through low vision specialists, who are specialized optometrists, and also through our partner’s dealer network of low vision distributors. The glasses are sold on average at a price of $3K to $6K (priced in line with hearing aids). The retailer will potentially make roughly 20% to 30% margin. Cost of Goods is in the $500 to $1500 range, leaving a Gross Margin in the range of 50% to 70%. We also plan to distribute through general optometrists, which will produce similar profit margins. 

Our USA pilot partnership with Vispero is one in which they act as our distributor and support partner. This enables quicker servicing of the market and scalability, and lower expense overhead. This creates a lower need for working capital in sales, marketing and logistics. This can also potentially provide access to additional markets around the world in the future.


Eyedaptic’s current channels for lead generation and sales include direct to consumer advertising and referrals from local doctors. We will continue to 

test this model in the near future. However, once our product becomes more widely used and supported by MDs and ODs, we aim to develop a direct to consumer model, much like that of the hearing aid industry. 

What We Do


Simulating natural vision with ease and comfort!

At Eyedaptic, we make augmented reality (AR) glasses specialized for people with AMD. We first start with open market AR glasses that have satisfactory Field of View (FOV) 

How We Are Different


No other visual aid like ours exists on the market!

The basic concept for a product like ours was first conceived by NASA about 30 years ago. However, wearable electronic technology is relatively new. Until recently, a comfortable, mobile, wearable solution with the computing power to handle advanced image processing and machine learning algorithms simply did not exist.


Our proprietary software, which uses image enhancement, pixel remapping and machine learning, provides both enhanced vision as well as a natural viewing experience. 

*All images are of past prototypes or our production product. Final results may differ.

Our algorithms perform double duty, first analyzing images, then monitoring the embedded motion sensor data to infer the user’s focus of attention. In addition, the software enhances images to help the user see the real world more clearly and optimize their remaining peripheral vision.


Based on our surveys most visual aids on the market today are essentially magnification devices like magnifying glasses or CCTV systems. These only work for close up tasks, and are not hands free for mobility.

Our product is an FDA Class I Exempt device, which does not require FDA approval or clinical trials to go to market. Our visual aid allows for major cost savings and enables a more frequent product update cycle.


We believe based on feedback from our customers that competitors have tried to create similar concepts with Virtual Reality (VR), but the head mounted devices are heavy and cumbersome. Also, they isolate the user from the real world, handicapping the user by cutting off their peripheral vision entirely.

The Vision


We aim to be world leader in wearable visual aids

Eyedaptic’s ultimate mission is to be the leader in our space. We envision being the primary manufacturer of the market-leading wearable visual aid device that simulates natural vision. 

*All images are of past prototypes or our production product. Final results may differ.

OUR LEADERSHIP


A unique blend of expertise in technology, optometry, ophthalmology, engineering and business

CEO, Jay Cormier, and CTO, Dave Watola, are both experienced technology executives. They have had successful careers at both hardware and software companies with multiple successful exits under their belts. Their MD co-founders,  Dr. Mitul Mehta and Dr. Brian Kim, are both retina specialists who see many AMD patients on a daily basis. Both have software and engineering backgrounds to successfully bridge any gaps between the technology and the patient.

Our board of advisors are amongst world leaders in the fields of ophthalmology, optometry, and low vision specialization. All have long, successful track records in helping people with eye conditions. Our board of directors is composed of successful and experienced early-stage CEOs and investors.

Why Invest


Eyedaptic has proven efficacy and the ability to change millions of lives

Eyedaptic is serving one of the largest unmet needs in medical vision today, with over 150 million people affected worldwide (source, source, source, source)  Our one-of-a-kind AR visual aid solution enables AMD patients to perform everyday tasks and remain independent.

With multiple successful exits under our belts, a proven market model, and an experienced team that understands both the technology and medical fields, we have the necessary components to potentially make Eyedaptic the world leader in wearable visual aids. We have already secured investments from Tech Coast Angels, Band of Angels, and New York Angels, and members of the America Retina Forum. With your help and this raise, we are just one step closer to improving lives all over the world. 

*This testimonial may not be representative of the experiences of other customers and is not a guarantee of future performance or success.

In the Press

Sight Tech Global 2020
January 1, 2017

Write a summary of the article here, or the first 1-3 sentences of the article.

Eyedaptic Nominated as one of the Top Innovators in Orange County
January 1, 2017

Write a summary of the article here, or the first 1-3 sentences of the article.

Eyedaptic – 2020 High Tech Award Finalist
January 1, 2017

Write a summary of the article here, or the first 1-3 sentences of the article.

Easterseals

ATU474 – Eyedaptic with Jay Cormier

CEO-CFO Magazine

Using Augmented Reality Visual Aids with Proprietary Software, Eyedaptic, Inc. is optimizing and enhancing Peripheral Vision for people with Macular Degeneration or Loss of Central Vision

Village TV

Watch Eyedaptic’s co-founder Dr. Kim, give insights on Augmented Reality glasses to help those with AMD see a better future

SXSW Conference

Eyedaptic Selected As Finalist For 2020 SXSW Pitch

Macular Degeneration Foundation

Macular Degeneration Foundation Videos, Newsletters & Alerts

San Diego Business Journal

2019 Quick Pitch Competition Achieves Sold-Out Success

Offering Summary


Company

:

Eyedaptic, Inc.

Corporate Address

:

23421 South Pointe Drive, Laguna Hills, CA 92653

Offering Minimum

:

$10,000.00

Offering Maximum

:

$1,070,000.00

Minimum Investment Amount

(per investor)

:

$249.60











Terms


Offering Type

:

Equity

Security Name

:

Non-Voting Common Stock

Minimum Number of Shares Offered

:

12,500

Maximum Number of Shares Offered

:

1,337,500

Price per Share

:

$0.80

Pre-Money Valuation

:

$12,029,635.20











 COVID Relief

This offering is being conducted on an expedited basis due to circumstances relating to COVID-19 and pursuant to the SEC’s temporary regulatory COVID-19 relief set out in Regulation Crowdfunding §227.201(z).

Expedited closing sooner than 21 days

In reliance on Regulation Crowdfunding §227.303(g)(2) A funding portal that is an intermediary in a transaction involving the offer or sale of securities initiated between May 4, 2020, and February 28, 2021, in reliance on section 4(a)(6) of the Securities Act (15 U.S.C. 77d(a)(6)) by an issuer that is conducting an offering on an expedited basis due to circumstances relating to COVID-19 shall not be required to comply with the requirement in paragraph (e)(3)(i) of this section that a funding portal shall not direct transmission of funds earlier than 21 days after the date on which the intermediary makes publicly available on its platform the information required to be provided by the issuer under §§227.201 and 227.203(a).

*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Company Perks*

Time-Based:

Friends and Family Early Birds:

Invest within the first week and receive an additional 20% bonus shares

 Super Early Bird Bonus:

Invest within the first two weeks and receive an additional 15% bonus shares

Early Bird Bonus:

Invest within the first three weeks and receive an additional 10% bonus shares

 Last Chance Bonus:

Invest within the first four weeks and receive an additional 5% bonus shares

Amount-Based:

Amount-Based:

Tier 1:  $500+

Quarterly Investor Newsletter from the CEO

Tier 2:  $1,000+

5% Bonus Shares

Tier 3: $2,500+

5% Product Price Discount

Tier 4: $5,000+

5% Product Price Discount

5% Bonus Shares

Tier 5: $10,000+

10% Product Price Discount

 7% Bonus Shares

Tier 6: $25,000+

15% Product Price Discount

10% Bonus Shares

Tier 7: $50,000+

Early new product access for Beta product

15% Bonus Shares

*All perks occur when the offering is completed.

The 10% StartEngine Owners' Bonus

Eyedaptic, Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of non-voting common stock at $0.80/share, you will receive and own 110 shares for $80. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

*Concurrently with this offering, the Company may seek to raise funds in other offerings exempt from registration.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments. Salary payments made to one’s self, a friend or relative. Any expense labeled “Travel and Entertainment”.

Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$379,118.00 USD
$212,068.00 USD
Cash And Cash Equivalents
$363,254.00 USD
$184,512.00 USD
Accounts Receivable
$0.00 USD
$0.00 USD
Short Term Debt
$234,368.00 USD
$718,457.00 USD
Long Term Debt
$940,000.00 USD
$135,000.00 USD
Revenues And Sales
$62,313.00 USD
$5,580.00 USD
Costs Of Goods Sold
$38,398.00 USD
$4,522.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$687,050.00 USD
-$653,856.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Notice of Material Change in Offering

7 days ago

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the Eyedaptic offering. Here's an excerpt describing the specifics of the change:


Eyedaptic provided updated financials and extended the duration of their offering.


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

$400K Milestone Surpassed - Hurry Invest Now!

14 days ago

We are excited to announce that we have surpassed $400K in investments, and have some big news coming!


Learn more about Eyedaptic's mission to become the market-leading wearable visual aid device for those suffering from low vision and central vision impairments and invest today. 


A big thank you for everyone supporting Eyedaptic!


Eyedaptic News - Who's Who in America

16 days ago

Greetings Eyedaptic followers,


I am honored to share this latest news, regarding our Founder & CEO, with all of you.  You can read more here:

https://www.24-7pressrelease.com/press-release/481070/jay-cormier-has-been-inducted-into-the-prestigious-marquis-whos-who-biographical-registry


Thanks for your support of Eyedaptic!

Notice of Funds Disbursement

17 days ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Eyedaptic has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Eyedaptic be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Check out Eyedaptic on the Lighthouse Guild Podcast ON TECH & VISION

26 days ago

Greetings Eyedaptic Followers,


The Lighthouse Guild is dedicated to providing exceptional services that inspire people who are visually impaired to attain their goals. The CEO of the New York Lighthouse is Dr. Cal Roberts, former Executive VP and Chief Medical Officer of Bausch & Lomb.  We are featured on his podcast "Improving Visual Impairment with Technology".  You can listen to it here, enjoy!

https://eyedaptic.com/lighthouse-guild-podcast-on-tech-vision-eyedaptic/


Thanks for supporting the future of Augmented Reality and Vision,

The Eyedaptic Team

Notice of Funds Disbursement

29 days ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Eyedaptic has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Eyedaptic be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Augmented Reality Technology News - Wall Street Journal!

30 days ago

Hello Eyedaptic Followers,


Another great article in the Wall Street Journal this morning on Augmented Reality technology.  Eyedaptic is ready to utilize and integrate the latest technology, and exploit the rapid acceleration of AR glasses!  Here is the article for your reading pleasure:

https://www.wsj.com/articles/facebook-apple-and-niantic-bet-people-are-ready-for-augmented-reality-glasses-11617713387


Note:  take a good look at the glasses picture in the print version - look familiar?


Stay tuned for more Augmented Reality news and thanks for following,

The Eyedaptic Team

Augmented Reality Technology News - $22B for Microsoft Holo Lens!

about 1 month ago

Hi Eyedaptic supporters,


More big news this week in the Augmented Reality space as Microsoft was awarded a $22B (yes that's billion) contract from the US government.  Read more here on the advances in AR hardware:

https://www.windowscentral.com/microsofts-bet-hololens-paying


Eyedaptic is poised to take advantage of the best AR hardware with our industry leading software!  Stay tuned for future news on our plans with these various hardware platforms.


Thanks for supporting the future of Augmented Reality and vision,

The Eyedaptic Team

The Latest Augmented Reality Technology News – Hurry & Invest Now!

about 1 month ago

Hello Eyedaptic Followers,

 

Here is some of the latest news from Facebook on their developments in Augmented Reality:

https://tech.fb.com/inside-facebook-reality-labs-the-next-era-of-human-computer-interaction/

I can’t help but note some of the common ground we have in developing adaptive user interfaces for glasses wearers.  Here is an excerpt from the full article:

TL;DR: In today’s post — the first in a series exploring the future of human-computer interaction (HCI) — we’ll begin to unpack the 10-year vision of a contextually-aware, AI-powered interface for augmented reality (AR) glasses that can use the information you choose to share, to infer what you want to do, when you want to do it.

Check it out, and stay tuned for some more announcements from Eyedaptic in this area coming soon!


Thanks for supporting the future of Augmented Reality and vision,

The Eyedaptic Team


Watch Vision Tech Talks #3 & see how much the EYE2 Improves Vision!

about 1 month ago

Greetings Eyedaptic Followers,


Watch and see how we benchmark users to quantify their vision improvement with the Eyedaptic glasses.  Sam's advancement with the EYE2, measured by a standardized reading test, is astounding!!

https://www.youtube.com/watch?v=3hD9JjVGfik&t=9s


Enjoy the video,

The Eyedaptic Team

Notice of Funds Disbursement

about 2 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Eyedaptic has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Eyedaptic be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Eye Disease becomes more personal!

about 2 months ago

Hello Eyedaptic Supporters,

This week eye disease just got more personal as my Dad was diagnosed with AMD (Age-Related Macular Degeneration) in one of his eyes as he was preparing for cataract surgery.  He is 86, recently remarried, and going strong!  He has a new found interest in our technology as he has no intentions of slowing down!!

I wanted to thank everyone for supporting our mission to help those with low vision and AMD!


Thanks for funding the future of visual aids,

Jay




Hear how Eyedaptic's EYE2 glasses are a game changer - Watch Vision Tech Talks video #2!

2 months ago

Hello Eyedaptic Followers,


Have a look at the next in the series where our user Sam discusses the impact the EYE2 has made in his life, with our Chief Medical Officer Dr. Mitul Mehta.  This has been a life changer for Sam, watch and hear how!

https://www.youtube.com/watch?v=vqL8JC26jUU&t=4s


Enjoy the video and thanks for your support!

The Eyedaptic Team


Eyedaptic Beta testing going great!

2 months ago

Hello Eyedaptic Supporters,

Beta testing is going well, and we are deploying more EYE3's for in home testing.  We also started benchmarking the EYE4 and are delighted with the results!


Here are some pictures of our Beta user Sam who you met in the first Vision Tech Talks video, and stay tuned for more on Sam's low vision journey and progress on our new products.


Thanks for your support and funding the future of adaptive visual aids!




Welcome to Vision Tech Talks - watch the Video!

3 months ago

Hi Eyedaptic Followers,


We are excited to share the first in a series of our new Vision Tech Talks!  These videos will help to show how Eyedaptic can assist those with central vision loss and other low vision impairments.  This will include how our technology can make an impact for real people in their everyday living!!  


https://www.youtube.com/watch?v=33fE7fY37eY


Enjoy watching and thanks for your support,

The Eyedaptic Team





Notice of Funds Disbursement

3 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Eyedaptic has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Eyedaptic be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Eyedaptic is a Semi Finalist in the San Diego Angel Conference

3 months ago

Greetings Eyedaptic Supporters,


More great news for Eyedaptic from the investment community.  Hurry and invest now before more Angel Investors fill out the round!


The San Diego Angel Conference (SDAC), a three-year-old University of San Diego (USD) School of Business program that activates accredited angel investors and engages promising early-stage companies, has selected Eyedaptic as one of the 15 Semi Finalists to compete in this year’s Conference.

In the first round of selections, angel investors spent weeks reviewing materials before selecting the top 30 companies that advanced to the Quarter Finals.  Investors spent two weeks evaluating pitches, and reviewing materials before selecting 15 companies who will compete in the Semi Finals.

Companies will continue to compete until the finale for an investment estimated to be $200,000.


Thanks for your support!

The Eyedaptic Team


https://www.linkedin.com/feed/update/urn:li:activity:6764941792040357888/



Final Early Bird Bonus Ends Tuesday!!

3 months ago

Greetings Eyedaptic Supporters,


Our final early bird bonus is ending this Tuesday, so hurry and invest now!


For your viewing pleasure I have attached a webinar from Sight Tech Global 2020, which was focused on the cutting edge of AI-related technologies and accessibility, especially for the blind and visually impaired.  This introduces one of Eyedaptic's users and is titled: Simulated Natural Vision Technology & One User’s Low Vision Journey.  

https://eyedaptic.com/sight-tech-global-2020/


Enjoy watching and thank you for your support!

The Eyedaptic Team


Notice of Funds Disbursement

3 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Eyedaptic has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Eyedaptic be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

$300K Milestone Surpassed & Early Bird Bonus Ending!

3 months ago

We are excited to announce that we have surpassed $300K in investments in less than 3 weeks after launch!

Please note, Early Bird incentives will expire today.


Learn more about Eyedaptic's mission to become the market-leading wearable visual aid device for those suffering from AMD (age-related macular degeneration) and other central vision impairments and invest today. 


A big thank you for everyone supporting Eyedaptic!

Big News! Eyedaptic Granted Patent

4 months ago

Hello Eyedaptic Followers,

I wanted to share this great news with everyone on a press release that will be going out on Business Wire:

"Eyedaptic announced they were recently granted their first out of nine pending patents. The patent protects Eyedaptic’s intellectual property and low vision technology including the image processing and machine learning software algorithms as well as the adaptive systems used to simulate natural vision." 

In addition to the recent patent grant and patents pending we have even more being filed in the next few months.  In addition to the Eyedaptic Trademarks, this is the first of a number of important milestones for our Intellectually Property portfolio that helps protect our technology and build value for the enterprise.

Thanks again for your support of Eyedaptic!

Great Launch & Big News Coming!

4 months ago

Greetings Eyedaptic Investors & Supporters,


Thanks to all for making this launch a success, we surpassed our first major milestone and raised over 20% in the first week!  Our next early bird expires in a few days so if you are interested in investing and supporting the Eyedaptic mission don't wait - invest now.  We have some big news coming up mid next week so stay tuned!


All the best,

The Eyedaptic Team

Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Please sign in to post a comment.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}